期刊文献+

鸭坦布苏病毒E蛋白结构域III原核表达产物诱导中和抗体的研究 被引量:7

PROKARYOTIC EXPRESSION OF DOMAIN III OF ENVELOPE PROTEIN OF DUCK TEMBUSU VIRUS AND CHARACTERIZATION OF NEUTRALIZING ANTIBODY RESPONSES
在线阅读 下载PDF
导出
摘要 黄病毒E蛋白结构域Ⅲ能够介导病毒与宿主受体结合以及诱导产生中和抗体,本研究利用原核表达系统表达了鸭坦布苏病毒E蛋白结构域Ⅲ,并研究了其免疫原性。按照大肠杆菌偏好性密码子对鸭坦布苏病毒E蛋白结构域Ⅲ核苷酸序列进行优化并合成后,克隆至pCold-TF载体构建重组质粒pCold-TF-optiEDIII。Western blot证实重组蛋白能与鸭坦布苏病毒特异性血清发生反应。用纯化的重组蛋白免疫BLAB/c小鼠3次,间接ELISA和间接免疫荧光实验证实E蛋白结构Ⅲ诱导了鸭坦布苏病毒特异性的体液免疫反应。中和实验证实鸭坦布苏病毒E蛋白结构域Ⅲ可诱导产生中和抗体。本研究为进一步研制鸭坦布苏病毒诊断抗原和亚单位疫苗奠定了基础。 The domain III of envelope glycoprotein (E) of the flaviviruses has been shown to bind cellular receptors and elicit neutralizing antibodies. In the present study, recombinant domain III (DIII) of E protein of Duck Tembusu virus (DTMUV) was expressed in E.coli and its immunogenicity was evaluated using BALB/c mouse model. The coding sequence of DIII was optimized (optiDIII) according to the bias codon usages of E.coli and then cloned into the multiple cloning site of pCold-TF vector to construct the recombinant plasmid pCold-TF-optiDIII. Western blot analysis showed the recombinant protein could react specifically with DTMUV antiserum. The recombinant DIII was purified and used to immunize BALB/c mice three times. The humoral immune responses specific for DTMUV were demonstrated by ELISA and indirect immunofluorescene assay(IFA). Importantly, neutralizing antibodies against DTMUV were detected in mouse serum samples by microneutralizing test. These findings have indicated that the recombinant DIII can be used for development of diagnostic reagents and subunit vaccines of DTMUV.
出处 《中国动物传染病学报》 CAS 2014年第2期1-6,共6页 Chinese Journal of Animal Infectious Diseases
基金 自然科学基金(面上)项目(31172332) 上海市科技兴农重点攻关项目(沪农科攻字(2012)第2-6号) 上海市科委"创新行动计划"基础研究重点项目(12JC1410600) 上海市科委"创新行动计划"现代农业领域重点科技攻关项目(13391901601)
关键词 鸭坦布苏病毒 E蛋白 结构域III 中和抗体 Duck Tembusu virus envelope protein domain III neutralizing antibody
  • 相关文献

参考文献11

二级参考文献46

  • 1吴鹏,曹瑞斌,周斌,张羽,沈婷,陈溥言.乙脑病毒非结构蛋白NS1的原核表达及重组蛋白间接ELISA方法的初步建立[J].畜牧与兽医,2010,42(3):5-8. 被引量:11
  • 2Henchal EA, Putnak JR. The dengue viruses[J]. Clin Microbiol Rev, 1990, 3(4): 376-96.
  • 3Yauch LE, Shresta S. Mouse models of dengue virus infection and disease[J]. Antiviral Res, 2008, 80(2): 87-93.
  • 4Halstead SB, Deen J. The future of dengue vaccines [J]. Lancet, 2002, 360(9341): 1243-5.
  • 5Rey F A. Dengue virus envelope glycoprotein structure: new insight into its interactions during viral entry [ J ]. Proc Natl Acad Sci USA, 2003, 100(12): 6899-901.
  • 6Kroeger A, Nathan M, Hombach J. Dengue [J]. Nat Rev Microbiol, 2004, 2(5): 360-1.
  • 7Jaiswal S, Khanna N, Swaminathan S. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli [J]. Protein Expr Purif, 2004, 33(1):80-91.
  • 8Modis Y, Ogata S, Clements D, et al. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein [ J ]. J Virol,2005, 79(2): 1223-31.
  • 9Modis Y, Ogata S, Clements D, et al. A ligand-binding pocket in the dengue virus envelope glycoprotein [J]. Proc Natl Acad Sci USA, 2003, 100(12): 6986-91.
  • 10Crill WD, Roehrig JT. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells[J]. J Virol, 2001, 75(16): 7769-73.

共引文献192

同被引文献51

  • 1Chen Xue-ming,Li Chen-xi,Lin Wei-wei.一种针对鸭Tembusu病毒包膜蛋白Ⅱ结构域hi环独特交叉反应性表位的中和抗体可保护鼠动物模型感染鸭坦布苏病毒[J].中国预防兽医学报,2020,42(4):425-425. 被引量:4
  • 2刘鑫,刁有祥,陈浩,王蛟,孙晓艳,葛平萍,郝东敏.1株麻雀源坦布苏病毒的分离鉴定及全基因组序列分析[J].中国兽医学报,2015,35(2):201-206. 被引量:9
  • 3邓永强,秦鄂德.虫媒黄病毒包膜E蛋白的研究进展[J].军事医学科学院院刊,2006,30(6):575-579. 被引量:20
  • 4Chu J, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng M L. 2005, Inhibition of West Nile virus entry by us-ing a recombinant domain III from the envelope glycopro- tein[J]. Journal of General Virology, 86(Pt 2): 405-412.
  • 5Beasley D W, Barrett A D. 2002, Identification of neutralizing epitopes within structure domain III of the West Nile virus envelope protein[J]. Journal of Virology, 76(24): 13097- 13100.
  • 6Einhauer A, Jungbauer A. 2001, The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins[J]. Journal of Biochemical and Biophysical Methods, 49( 1-3 ) : 455-465.
  • 7Hermida L, Bernardo L, Martin J, Alvarez M, Prado I, L6pez C, Sierra Bde L, Martinez R, Rodriguez R, Zulueta A, P6rez A B, Lazo L, Rosario D, Guill6n G, Guzm6n M G. 2006, A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenie and protective in nonhuman primates [ J ]. Vaccine, 24 (16) : 3165-3171.
  • 8Huang X M, Han K K, Zhao D M, Liu Y Z, Zhang J F, Niu H M, Zhang K N, Zhu J N, Wu D M, Gao L, Li Y. 2013, Identification and molecular characterization of a novel fla- vivirus isolated from geese in China[J]. Research in Vet- erinary Science, 94(3): 774-780.
  • 9Kaufmann B, Rossmann M G. 2011, Molecular mechanisms in- volved in the early steps of flavivirus cell entry[J]. Microbes and Infection, 13 ( 1 ) : 1-9.
  • 10Kolaskar A S, Kulkarni-Kale U. 1999. Prediction of three-di- mensjonal structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus[J]. Virology, 261( 1 ) : 51-42.

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部